Finance

Beta
Lists
RLAY:NASDAQ
Relay Therapeutics Inc
$13.52
-7.02%
(-1.02) 1D
$13.01
-3.77% (-0.51)
Pre-market
Closed: Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RLAY...
Open
$14.54
High
$14.54
Low
$12.92
Mkt. cap
2.91B
Avg. vol.
4.39M
Volume
525.00
52-wk high
$17.47
52-wk low
$2.98
EPS
-$1.57
Beta
1.75
Shares outstanding
214.50M
No. of employees
193
Open
$14.54
High
$14.54
Low
$12.92
Mkt. cap
2.91B
Avg. vol.
4.39M
Volume
525.00
52-wk high
$17.47
52-wk low
$2.98
EPS
-$1.57
Beta
1.75
Shares outstanding
214.50M
No. of employees
193
Analyst outlook
Analyst Ratings
Based on 11 analysts giving stock ratings to RLAY in the past 3 months
Strong Buy
Buy
11
Hold
0
Sell
0
12 month forecast
Based on 11 Wall Street analysts offering 12 month price targets for RLAY in the last 3 months.
Highest
Current $13.52
$28.00 (+107.10%)
Average
$23.00 (+70.12%)
Lowest
$18.00 (+33.14%)
News stories
From sources across the web
About Relay Therapeutics Inc
CEO-
Employees193
Founded2015
Headquarters-
SectorBiotechnology
Websiterelaytx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
677.00K
-
7.00M
3.00M
Cost of goods sold
61.47M
67.89M
56.34M
70.56M
Cost of revenue
61.47M
67.89M
56.34M
70.56M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13.75M
12.50M
13.59M
11.03M
Operating expense
13.75M
12.50M
13.59M
11.03M
Total operating expenses
75.22M
80.39M
69.93M
81.59M
Operating income
-74.55M
-80.39M
-62.93M
-78.59M
Other non operating income
-633.00K
-165.00K
30.00K
-53.00K
EBT including unusual items
-70.38M
-74.15M
-54.89M
-73.29M
EBT excluding unusual items
-68.08M
-74.15M
-57.19M
-73.29M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-70.38M
-74.15M
-54.89M
-73.29M
Net profit margin
-10,395.13%
-
-784.14%
-2,443.03%
Earnings per share
-0.41
-0.43
-0.31
-0.41
Interest and investment income
7.10M
6.41M
5.71M
5.35M
Interest expense
-
-
-
-
Net interest expenses
7.10M
6.41M
5.71M
5.35M
Depreciation and amortization charges
-
-
-
-
EBITDA
-73.54M
-79.64M
-62.33M
-78.09M
Gain or loss from assets sale
615.00K
353.00K
35.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer